




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Atherosclerotic Disease (CAD/PAD)</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=5a6b0b97-bb84-467a-9e0b-b9c7e7de4b85</link>
        <description>Clinical Topic Feed: Atherosclerotic Disease (CAD/PAD)</description>
        <language>en</language>

        

                <item>
                    <title>DAPT-MVD: Extended DAPT Cuts CV Events After PCI in Multivessel CAD</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/07/22/17/25/DAPT-MVD</link>                    <description>Extending DAPT for an additional year reduced major adverse cardiovascular events (MACE) without increasing bleeding risk compared with aspirin alone among patients with multivessel coronary artery disease (MVCAD) who had no ischemic or bleeding events one year after PCI with a drug-eluting stent, according to results of the DAPT-MVD trial published July 15 in NEJM.</description>
                    <pubdate>1784749860000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Journal Wrap | PAD Screening Marker; Racial, Sex Disparities in M-TEER; More</title>
<link>/Latest-in-Cardiology/Articles/2026/07/01/01/Journal-Wrap</link>                    <description>The hottest research from various peer-reviewed journals &#226;€“ handpicked weekly by the ACC.</description>
                    <pubdate>1782907740000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC Featured Jobs For July 2026</title>
<link>/Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs</link>                    <description>Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career!</description>
                    <pubdate>1782902880000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Implications of the 2026 ACC/AHA/Multisociety Dyslipidemia Guideline for Lipid Management in Vascular Disease</title>
<link>/Latest-in-Cardiology/Articles/2026/06/15/14/16/Implications-of-the-2026-Multisociety-Dyslipidemia-Guideline</link>                    <description>Lipid management remains a cornerstone of secondary prevention in atherosclerotic cardiovascular disease (ASCVD), with increasingly strong evidence supporting its central role across all vascular territories, including coronary, cerebrovascular, and peripheral arterial beds.</description>
                    <pubdate>1781629980000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>VitaK-CAC: Menaquinone-7 Attenuates CAC in CAD</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/06/15/17/15/VitaK-CAC</link>                    <description>Supplementation with the vitamin K homologue menaquinone-7 (MK-7) significantly attenuated coronary artery calcification (CAC) compared with placebo in adults with symptomatic coronary artery disease (CAD), according to research published June 10 in JAMA Cardiology.</description>
                    <pubdate>1781617080000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Optimizing Dual Antiplatelet Therapy in Patients With Diabetes and Multivessel Disease Undergoing PCI: The TUXEDO-2 Trial</title>
<link>/Latest-in-Cardiology/Articles/2026/06/08/10/20/Optimizing-Dual-Antiplatelet-Therapy</link>                    <description>The TUXEDO-2 (Ultrathin Strut vs. Xience in a Diabetic Population With Multivessel Disease 2&#226;€”India Study) trial demonstrated that among patients with diabetes mellitus and multivessel coronary artery disease undergoing percutaneous coronary intervention (PCI)...</description>
                    <pubdate>1781024040000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>QI.PI Project Grant Recipient Develops Digital Biomarker For PAD Screening</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/06/08/17/44/QI-PI-Project-Grant-Recipient</link>                    <description>A quick, noninvasive toe-based light measurement combined with artificial intelligence demonstrated efficacy in screening for peripheral artery disease (PAD), according to a recent study published in npj Digital Medicine by a 2024 recipient of an ACC Accreditation Services&#39; QI.PI Project Grant.</description>
                    <pubdate>1780947000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>EWAS Identifies Associations Between DNA Methylation, Atherosclerosis</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/06/03/20/12/EWAS-Identifies-Associations-Between-DNA-Methylation-Atherosclerosis</link>                    <description>An epigenome-wide association study (EWAS) identified a large number of associations between DNA methylation and carotid, coronary and peripheral atherosclerosis, with &amp;gt;90% of sites traceable to the epigenetic signatures of cardiovascular risk factors, predominantly smoking, according to research published June 3 in JACC.</description>
                    <pubdate>1780675380000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>New Studies Point to Emerging Strategies For HFrEF, Familial Hypercholesterolemia</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/06/02/15/27/New-Studies-Point-to-Emerging-Strategies-For-HFrEF</link>                    <description>Results from two early studies published in NEJM could have important implications for patients with heart failure (HF) and reduced LVEF and for adults with heterozygous familial hypercholesterolemia (HFH) or premature coronary artery disease, respectively.</description>
                    <pubdate>1780493820000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Journal Wrap | HCM Risk Stratification; Single Pill Combo Cuts BP, Stroke</title>
<link>/Latest-in-Cardiology/Articles/2026/06/01/01/Journal-Wrap</link>                    <description>The hottest research from various peer-reviewed journals &#226;€“ handpicked weekly by the ACC.</description>
                    <pubdate>1780315620000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>